glp-1 drugs in development Emerging Trends the of Receptor Agonists GLP-1 Drugs Market Size to
Description
Another key benefit of natural goods over synthetic medications is their intrinsic safety profile
& Kiens, B
Both the combined results of the IVW method (OR common-effect-model = 0.43 [95%CI 0.260.72], OR random-effects-model = 0.42 [95%CI 0.240.76]) and the SMR method (OR common-effect-model = 0.97 [95%CI 0.960.99], OR random-effects-model = 0.97 [95%CI 0.951.00]) showed the consistent trend with the separate results(Fig
JAMA 329 , 13761385 (2023)
